Company: CRL
Filing Date: 2025-04-02
Form Type: DEF 14A
Source: 0001104659-25-030908
Chunk: 86

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-04-02
Form: DEF 14A
Chunk 86
---
 | ​ | ​                               | ​ |  1,726,452 | ​ | ​ |
| Joseph LaPlume   | ​ | ​ | ​                                   | ​ |       — | ​ | ​ | ​ | ​                                          | ​ |  82,333 | ​ | ​ | ​ | ​                              | ​ |   121,515 | ​ | ​ | ​ | ​                                      | ​ | — | ​ | ​ | ​ | ​                               | ​ |    960,810 | ​ | ​ |

(1) For purposes of consistency, the amounts shown in this table include only those contributions, earnings, withdrawals, and distributions that occurred during calendar year 2024. Accordingly, amounts credited by us with respect to compensation earned in the last fiscal year, but which are credited in 2025, have not been included in this table. However, these amounts (Mr. Foster, $0; Ms. Pease, $83,455; Ms. Creamer, $68,312; Ms. Girshick, $97,179; and Mr. LaPlume, $70,449) have been included in the total compensation set forth in the Summary Compensation Table under the column entitled “All Other Compensation”. As further discussed in the narrative above, the amounts set forth in the column entitled “Registrant Contributions in Last FY” represent the present value of the accrued benefits, after adjustments for outstanding Medicare taxes, which were credited to the named executives’ Deferred Compensation Plan account balances. (2) The amounts listed under the column “Registrant Contributions in Last FY” in this table and in prior years have been reported as compensation in the Summary Compensation Table for previous fiscal years.

64

Potential Payments upon Termination or Change in Control The information below describes and quantifies certain compensation that would become payable under existing plans and arrangements if the named executive’s employment had terminated on December 28, 2024, given the named executive’s compensation and service levels as of such date and, if applicable, based on our closing stock price on that date. (Since our last trading day in fiscal year 2024 was December 27, 2024, where applicable we have assumed a stock price of $186.16, the closing price on that date). Due to the number of factors that affect the nature and amount of any benefits provided upon the events discussed below, any actual amounts paid or distributed may be different. Factors that could affect these amounts include the timing during the year of any such event, our